GHRP-2 Synchronizes Three Different Hormone Pulses in Critically Ill Patients
Continuous GHRP-2 infusion synchronized the pulsatile release of GH, TSH, and prolactin in critically ill patients, suggesting these hormones share a common regulatory mechanism that GHRP-2 can reactivate.
Quick Facts
What This Study Found
Continuous GHRP-2 infusion synchronized the pulsatile release of GH, TSH, and prolactin in critically ill patients, revealing a common hypothalamic regulatory mechanism that can be pharmacologically reactivated.
Key Numbers
How They Did This
Clinical trial in prolonged critically ill patients. Continuous GHRP-2 IV infusion with frequent blood sampling (every 10-20 minutes) for GH, TSH, and prolactin. Pulse analysis and cross-correlation performed.
Why This Research Matters
The synchronization finding reveals fundamental neuroendocrine biology — a shared oscillator for three pituitary hormones. Clinically, it means GHRP-2 may restore multiple hormonal axes simultaneously in critical illness.
The Bigger Picture
Critical illness suppresses multiple hormone systems simultaneously. Finding that a single peptide can reactivate and synchronize multiple axes suggests a common mechanism of suppression and a unified therapeutic approach.
What This Study Doesn't Tell Us
Intensive sampling protocol limits to small patient numbers. Hormonal synchronization doesn't guarantee clinical benefit. The hypothalamic oscillator hypothesis needs further validation.
Questions This Raises
- ?Does hormonal synchronization improve clinical outcomes?
- ?What is the hypothalamic oscillator that GHRP-2 reactivates?
- ?Can this synchronization be achieved with less invasive GHRP administration?
Trust & Context
- Key Stat:
- 3 hormones synchronized GHRP-2 caused GH, TSH, and prolactin pulses to occur simultaneously — evidence for a shared hypothalamic oscillator
- Evidence Grade:
- Moderate evidence from an intensive clinical study with detailed hormonal profiling, providing novel insights but limited by small sample inherent to the intensive methodology.
- Study Age:
- Published in 1999. The concept of a common hypothalamic pulse generator reactivated by GH secretagogues remains an important area of neuroendocrine research.
- Original Title:
- Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.
- Published In:
- European journal of endocrinology, 140(1), 17-22 (1999)
- Authors:
- Van den Berghe, G(10), Wouters, P(7), Bowers, C Y(21), de Zegher, F, Bouillon, R, Veldhuis, J D
- Database ID:
- RPEP-00570
Evidence Hierarchy
Frequently Asked Questions
Why do ICU patients lose hormone pulses?
The brain normally releases hormones in rhythmic pulses, especially at night. Critical illness suppresses the hypothalamic oscillator that generates these pulses, disrupting multiple hormone systems simultaneously.
Can one drug fix multiple hormone problems?
This study suggests yes — GHRP-2 restored and synchronized pulses of three different hormones, implying it reactivates the shared brain mechanism that controls them. This is more efficient than replacing each hormone separately.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00570APA
Van den Berghe, G; Wouters, P; Bowers, C Y; de Zegher, F; Bouillon, R; Veldhuis, J D. (1999). Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.. European journal of endocrinology, 140(1), 17-22.
MLA
Van den Berghe, G, et al. "Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.." European journal of endocrinology, 1999.
RethinkPeptides
RethinkPeptides Research Database. "Growth hormone-releasing peptide-2 infusion synchronizes gro..." RPEP-00570. Retrieved from https://rethinkpeptides.com/research/van-1999-growth-hormonereleasing-peptide2-infusion
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.